× |
|
GLUCONOLACTONE Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
EDETATE DISODIUM Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
ETHYLCELLULOSES Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
EXFORGE HCT (amlodipine besylate; hydrochlorothiazide; valsartan) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
× |
|
DULERA (formoterol fumarate; mometasone furoate) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
× |
|
D&C YELLOW NO. 10 ALUMINUM LAKE Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
SODIUM ACETATE ANHYDROUS Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
POWDERED CELLULOSE Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
FUMARIC ACID Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
CYSTEINE HYDROCHLORIDE Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
SODIUM PROPIONATE Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|